BNF for Children (BNFC) 2026-2027

Product Description

The first choice for concise medicines information for children. Practical and evidence-based, BNF for Children (BNFC) is the only child-focused drug formulary in the world that is both independent, and has rigorous, accredited content creation processes.

Significant changes made since the release of data for the print edition of BNFC 2026 — 2027:

Antibacterials, principles of therapy: updated guidance on notifiable diseases.

Ceftriaxone: new indication and dose for sepsis.

Xylometazoline hydrochloride: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse [MHRA/CHM advice].

Xylometazoline hydrochloride: update to maximum duration of use for nasal congestion.

Other changes since the print edition of BNFC 2026 — 2027:

Changes in dose, Classification changes, New monographs, New preparations, Deleted monographs & Deleted preparations